6.
Chen J, Zhou J, Chen X, Yang B, Wang D, Yang P
. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2. Tumour Biol. 2015; 36(10):8221-9.
DOI: 10.1007/s13277-015-3568-y.
View
7.
Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W
. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2020; 500:1-10.
DOI: 10.1016/j.canlet.2020.12.024.
View
8.
Wei X, Wang B, Wang Q, Yang X, Yang Y, Fang Z
. MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI. Front Pharmacol. 2020; 11:164.
PMC: 7063466.
DOI: 10.3389/fphar.2020.00164.
View
9.
Ren G, Ma Z, Hui M, Kudo L, Hui K, Karsten S
. Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA/NPEPPS): PSA/NPEPPS is a possible modifier of amyotrophic lateral sclerosis. Mol Neurodegener. 2011; 6:29.
PMC: 3113298.
DOI: 10.1186/1750-1326-6-29.
View
10.
Matsunaga T, Endo S, Maeda S, Ishikura S, Tajima K, Tanaka N
. Characterization of human DHRS4: an inducible short-chain dehydrogenase/reductase enzyme with 3beta-hydroxysteroid dehydrogenase activity. Arch Biochem Biophys. 2008; 477(2):339-47.
DOI: 10.1016/j.abb.2008.06.002.
View
11.
Zhou Y, Li K, Zou X, Hua Z, Wang H, Bian W
. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Bioengineered. 2021; 12(2):10862-10877.
PMC: 8809963.
DOI: 10.1080/21655979.2021.1994719.
View
12.
Wu F, Yin C, Qi J, Duan D, Jiang X, Yu J
. miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia. Hum Cell. 2020; 33(2):405-415.
PMC: 7080691.
DOI: 10.1007/s13577-019-00319-4.
View
13.
Chen M, Wu X, Ma W, Zhou Q, Wang X, Zhang R
. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer Biomark. 2017; 21(1):23-28.
DOI: 10.3233/CBM-170172.
View
14.
Utnes P, Lokke C, Flaegstad T, Einvik C
. Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma. Cancer Inform. 2019; 18:1176935119832910.
PMC: 6413431.
DOI: 10.1177/1176935119832910.
View
15.
Yanagi K, Tanaka T, Kato K, Sadik G, Morihara T, Kudo T
. Involvement of puromycin-sensitive aminopeptidase in proteolysis of tau protein in cultured cells, and attenuated proteolysis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) mutant tau. Psychogeriatrics. 2010; 9(4):157-66.
DOI: 10.1111/j.1479-8301.2010.00307.x.
View
16.
Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C
. Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis. Cell Death Dis. 2017; 8(6):e2888.
PMC: 5520904.
DOI: 10.1038/cddis.2017.245.
View
17.
Huang D, Ichikawa Y
. Purification and characterization of a novel cytosolic NADP(H)-dependent retinol oxidoreductase from rabbit liver. Biochim Biophys Acta. 1997; 1338(1):47-59.
DOI: 10.1016/s0167-4838(96)00183-5.
View
18.
Wang C, Wang G, Zhang Z, Wang Z, Ren M, Wang X
. The downregulated long noncoding RNA is protumoral and associated with the prognosis of clear cell renal cell carcinoma. Onco Targets Ther. 2018; 11:5631-5646.
PMC: 6141115.
DOI: 10.2147/OTT.S164984.
View
19.
Yang Y, Su Z, Song X, Liang B, Zeng F, Chang X
. Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster. Sci Rep. 2016; 6:20961.
PMC: 4750091.
DOI: 10.1038/srep20961.
View
20.
Heymann M, Brown H, Heymann D
. Drugs in early clinical development for the treatment of osteosarcoma. Expert Opin Investig Drugs. 2016; 25(11):1265-1280.
DOI: 10.1080/13543784.2016.1237503.
View